Fund Name: Abingworth Clinical Co-Development Fund 2
Fund size: $582 million
Target size: $350 million
Launch date: August 2020
Current Status: Final close, May 2021
Abingworth has held a final close on its Abingworth Clinical Co-Development Fund 2, raising $582 million. The fund will invest in late-stage product financing from biotech and pharmaceutical companies. The firm also closed its Abingworth Bioventures 8 fund, which raised $465 million, in February of this year.
